Recommendations of the 7th Consensus Conference of the SEMICYUC. Severe acute pancreatitis in intensive medicine;Recomendaciones de la 7a Conferencia de Consenso de la SEMICYUC. Pancreatitis aguda grave en medicina intensiva

Medicina Intensiva

Volumn 29, Issue 5, 2005, Pages 279-304

  Maravi Poma E ^a   Jimenez Urra I ^a   Raxarch, J Gener ^b   Zubia Olascoaga, F ^c   Perez Mateo M ^d   Casas Curto, J D ^b   Montejo Gonzalez J C ^e   Garcia De Lorenzo A ^f   Lopez Camps V ^g   Fernandez Mondejar E ^h   Alvarez Lerma F ⁱ   Valles Daunis J ^j   Olaechea Astigarraga, P ^k   Dominguez Munoz E ^l   Tellado Rodriguez J Ma ^m   Landa Garcia I ^e   Lafuente Martinez J ^m   Villalba Martin C ⁿ   Sesma Sanchez J ^a  

^a Universidad Pública de Navarra   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c Centro Hospitalario Donostia   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f Hospital U   (Spain)

^g HOSPITAL DE SAGUNTO   (Spain)

^h Hospital de Rehabilitación y Traumatología   (Spain)

ⁱ HOSPITAL DEL MAR   (Spain)

^j HOSPITAL DE SABADELL   (Spain)

^k HOSPITAL DE GALDAKAO   (Spain)

^l Instituto de Salud Carlos III   (Spain)

^m HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

ⁿ HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

more..

Author keywords

Antibiotics; Consensus Conference; ICU; Intensives; Multiorgan dysfunction; Pancreatic sepsis; Recommendations; Severe acute pancreatitis; Surgery

Indexed keywords

MEROPENEM;

ACUTE PANCREATITIS; ANTIBIOTIC PROPHYLAXIS; ASSISTED VENTILATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUING EDUCATION; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HUMAN; INTENSIVE CARE; MEDICAL SOCIETY; MENTAL DETERIORATION; PANCREAS ABSCESS; PANCREAS NECROSIS;

EID: 23144444096     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5691(05)74245-5     Document Type: Conference Paper

References (255)

1. Carballo Álvarez F. Epidemiología de la pancreatitis aguda: ¿es igual el riesgo en todos los países y regiones de España? En: Medicina Crítica Práctica. Pancreatitis aguda grave, manejo integral. Ed. Barcelona: SEMICYUC y EDIKA-med; 2003. p. 29-40.
2. Maraví-Poma E, Bermejo B, Lander A, Martínez JM, Escuchuri J y GTEI-SEMICYUC. Estudio Nacional de Vigilancia de Infección Nosocomial y pancreatitis aguda grave en UCI. Estudio multicéntrico español. Med Intensiva. 2002;26:C102.
3. Maraví-Poma E, Gener J, Álvarez-Lerma F, Olaechea P, Blanco A, Domínguez-Muñoz JE and Spanish Group for the Study of Septic Complications in Severe Acute Pancreatitis. Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenemcilastatin. Intensive Care Med. 2003;29:1974-80.
4. Bassi C, Larvin M, Villatoro E. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis (Cochrane Review). En: The Cochrane Library, Issue 4. Chichester, UK: John Wiley & Sons, Ltd; 2003.
5. Isenmann R, Runzi M, Kron M, Kahl S, Kraus D, Jung N, et al. and The German Antibiotics in Severe Acute Pancreatitis (ASAP) Study Group. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: A placebo-controlled, double blind trial. Gastroenterology. 2004;126:997-1004.
6. Maraví Poma E, Domínguez Muñoz E, Gener Raxarch J, de la Torre MV. Pancreatitis aguda grave: concepto y definiciones. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave, Manejo integral. Barcelona: Ed. SEMICYUC y EDIKA-med; 2003. p. 1-8.
7. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:854-75.
8. Philips R, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Oxford Centre for Evidence-Based Medicine Levels of Evidence. Levels of Evidence and Grades of Recommendations. Disponible en: http://www.cebm.net/ levels_of_evidence.asp#refs. Consultado: 18 Octubre 2003.
9. Sesma Sánchez J, de la Torre MV, Vila Costas JJ, del Baño Aledo MD, Maraví-Poma E. La pancreatitis aguda en Urgencias y Digestivo: estratificación pronostica precoz de la gravedad; indicaciones de tomografía axial computerizada precoz; Indicación de ingreso en Medicina Intensiva. Manejo inicial. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave, Manejo integral. Barcelona: Ed. SEMICYUC y EDIKA-med; 2003. p. 63-74.
10. Fernández Castroagudín J, Domínguez Muñoz JE, Gener Rexach J, Tellería Martín A. Diagnóstico y laboratorio en la pancreatitis aguda grave: historia natural de la necrosis pancreática. Marcadores plasmáticos de necrosis pancreática de gravedad y evolutivos. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave, Manejo integral. Barcelona: Ed. SEMICYUC y EDIKA-med; 2003. p. 19-28.
11. Fernández Castroagudín J, Iglesias J, Domínguez Muñoz JE. Estratificación del riesgo: marcadores bioquímicos y escalas pronosticas en la pancreatitis aguda. Med Intensiva. 2003;27:93-100.
12. Venkatesan T, Moulton JS, Ulrich CD. Prevalence and predictors of severity as defined by Atlanta criteria among patients presenting with acute pancreatitis. Pancreas. 2003;26:107-10.
13. Blum T, Maisonneuve P, Lowenfwls AB. Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology. 2001;1:237-41.
14. Mutinga M, Rosenbluth A, Tenner SM. Does mortality occur early or late in acute pancreatitis? Int J Pancreatol. 2000;28:91-5.
15. Olaechea Astigarraga PM, Maraví Poma E, Repáraz Abaitua F, Manrique Larralde A. Factores pronósticos, morbilidad y mortalidad de la pancreatitis aguda grave estéril e infectada. En: Medicina Crítica Práctica. Pancreatitis aguda grave: Manejo Integral. Barcelona: Ed. SEMICYUC y EDIKA-Med; 2003. p. 165-76.
16. Berger HG, Bittner R, Block S, Büchler M. Bacterial contamination of pancreatic necrosis: a prospective clinical study. Gastroenterology. 1986;91:433-8.
17. Lumsden A, Bradley EL III. Secondary pancreatic infections. Surg Gynecol Obstet 1990;170:459-67.
18. Bradley EL III. A clinically based classification system for acute pancreatitis. Arch Surg. 1993;128:586-90.
19. Pérez-Mateo M, Martínez J. Fisiopatología y patogenia de la pancreatitis aguda grave. Humana y experimental. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave, Manejo integral. Barcelona: Ed. SEMICYUC y EDIKA-med; 2003. p. 9-18.
20. Oller B, Armengol M, de Castro J, Iglesias C, Gener J, Inaraja L, et al. Correlation of etiology and severity in a series of 506 cases of acute pancreatitis [Article in Spanish]. Rev Esp Enferm Apar Dig. 1989;76:640-4.
21. Zubia Olascoaga F, Zabarte M, Iriarte M, Ruiz I, Sebastian R, Alberdi F. Pancreatitis aguda severa ¿Cuándo y por qué operamos? Med Intensiva. 2004;28(Supl 1):72.
22. Caballero Zirena A, Cortés Díaz S, Álvarez Terrero A. Severe acute pancreatitis: evaluation of pronostic indicators. Intensive Care Med. 2004;30:S124.
23. Zubia F, Alberdi F, Reviejo K, Sanmartin I, Sebastian R, Trabanco S. Complicaciones infecciosas locales en las pancreatitis agudas severas. Med Intensiva. 2003;27:286.
24. Marcos Neira P, Gener J, Mesalles E, Bordejé L, Misis M. Sindrome compartimental y pancreatitis: consecuencias clínicas terapéuticas y pronóstico. Med Intensiva. 2003;27:287.
25. Zubia F, Alberdi F, Reviejo K, Sebastián R, Trabanco S, Sanmartin I. Análisis de la mortalidad por pancreatitis en cuidados intensivos. Med Intensiva. 2003;27:288.
26. Andrade Vivero G, Sotillo Díaz J, Cremades Navalón I, Villanova Martínez M, Bueno García B, Domínguez Pardo E. Pancreatitis necrotizante aguda grave. Evolución y mortalidad. Med Intensiva. 2003;27:289.
27. Sierra Camerino S, Díaz Sese R, Benítez Rodríguez E, Guerrero Altaminero A, Lozano Cintado O, Valiente Alemán I, et al. Desenlace crítico de pancreatitis aguda grave con disfunción multiorgánica. Med Intensiva. 2003;27:286.
28. Sierra Camerino S, Díaz Sese R, Guerrero Altaminero A, Lozano Cintado O, Valiente Alemán I, Pedraza López S. Características de una serie de casos de pancreatitis aguda en una UCI. Med Intensiva. 2003;27:289.
29. Bautista Rodríguez M, Chirosa Ríos M, Bravo Rodríguez F, Morán Moliz F, Serrano Simón J, Sancho Ruiz H. Pancreatitis aguda grave. Estudio de factores pronósticos. Med Intensiva. 2003;27:290.
30. Fernández-Cruz L, Navarro S, Valderrama R, Sáenz A, Guarner L, Aparisi L, et al. Acute necrotizing pancreatitis: a multicenter study. Hepatogastroenterol. 1994;41:185-9.
31. Obon Azuara B, Gutiérrez I, Villanueva B, Bustamante R, Ridruejo R, González J. Pancreatitis aguda grave en los Servicios de Medicina Intensiva. Med Intensiva. 2004;28(Supl):72.
32. Karimgani I, Porter K, Langevin R, Banks PA. Prognostic factors in sterile pancreatic necrosis. Gastroenterology. 1992;103:1636-40.
33. Bradley EL III, Allen K. A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis. Am J Surg. 1991;161:19-24.
34. Rattner DW, Legemate DA, Mueller PR, Warshaw AL. Early surgical desbridement of pancreatic necrosis is beneficial irrespective of infection. Am J Surg. 1992;163:105-10.
35. Allardyce D. Incidence of necrotizing pancreatitis and factors related to mortality. Am J Surg. 1987;154:295-9.
36. Tenner S, Sica, G, Hughes M, Noordhoek E, Feng S, Zinner M, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology. 1997;113:899-903.
37. Lankisch PG, Pflichthofer D, Lehnik D. No strict correlation between necrosis and organ failure in acute pancreatitis. Pancreas. 2000;20:319-22.
38. Gloor B, Uhl W, Müller CA, Büchler MW. The role of Surgery in the management of acute pancreatitis. Can J Gastroenterol. 2000;14 Supl:136D-40D.
39. Büchler MW, Gloor B, Müller CA, Friess H, Seiler CA, Uhl W. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg. 2000;232:619-26.
40. Martínez J, Sánchez-Payá J, Palazón JM, Suazo-Barahona J, Robles-Díaz G, Pérez-Mateo M. Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology. 2004;4:42-8.
41. Maraví Poma E, Manrique Larralde A, Ramos Castro J, Izura Cea J, Labayen Beraza F, Madurga Pérez MP. Lavado peritoneal y pancreatitis graves. Med Intensiva. 1986;10:42-50.
42. De Bolla A, Obeid M. Mortality in acute pancreatitis. Am R Coll Surg Engl. 1984;66:184-6.
43. Fan S, Choi T, Lai C, Wong J. Influence of age on the mortality from acute pancreatitis. Br J Surg. 1988;75:463-6.
44. Paajanen H, Jaakkola M, Oksanen H, Nordback I. Acute pancreatitis in patients over 80 years. Eur J Surg. 1996;162:471-5.
45. Nordback I, Sand J, Saaristo R, Paajanen H. Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis-a single-center randomized study. J Gastrointest Surg. 2001;5:113-8.
46. Imrie H, McKay A, Benjamín I, Blumgart LH. Secondary acute pancreatitis: aetiology, prevention, diagnosis and management. Br J Surg. 1978;65:399-402.
47. Thomson J, Braga L, Hodgson P, Rikkers LF. Postoperative pancreatitis. Surg Gynecol Obstet. 1988;167:377-80.
48. McMahon MJ, Playforth MJ, Pickford IR. A comparative study of methods for the prediction of severity of attacks of acute pancreatitis. Br J Surg. 1980;67:22-5.
49. Larvin M. Assessment of severity and prognosis in acute pancreatitis. Eur J Gastroenterol Hepatol. 1997;9:122-30.
50. Ranson JHC, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974;139:69-81.
51. Ranson JHC. The timing of biliary surgery in acute pancreatitis. Ann Surg. 1979;189:654-63.
52. Imrie CW, Benjamin IS, Ferguson JC, Mc Kay AJ, Mackenzie I, O'Neill J, et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg. 1978;65:337-41.
53. Osborne DH, Imrie CW, Carter DC. Biliary surgery in the same admission for gallstones-associated acute pancreatitis. Br J Surg. 1981;68:758-61.
54. Blarney SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC. Prognostic factors in acute pancreatitis. Gut. 1984;25:1340-6.
55. De Bernardis M, Violi V, Roncoroni L, Boselli AS, Giunta A, Peracchia A. Discriminant power and information content of Ranson's prognostic signs in acute pancreatitis: A meta-analytic study. Crit Care Med. 1999;27:2272-83.
56. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE-II, clinical assessment and multiple factor scoring systems. Br J Surg. 1990; 77:1260-4.
57. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet. 1989;2:201-5.
58. Domínguez-Muñoz, JE, Carballo F, García MJ, de Diego JM, Campos R, Yangüela J, et al. Evaluation of the clinical usefulness of APACHE-II and SAPS systems in the initial prognostic classification of acute pancreatitis: a multicenter study. Pancreas. 1993;24:263-6.
59. Toh SKC, Walters J, Johson CD. APACHE-O. A new predictor of severity in acute pancreatitis. Gastroenterology. 1996;110:A437.
60. Domínguez-Muñoz JE, Carballo F, García MJ, de Diego JM, Rábago I, Simón MA, et al. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicentre study. Br J Surg. 1991;78:1230-4.
61. Uhl U, Büchler M, Malfertheiner P, Martini M, Beger HG. PMN elastase in comparison with CRP, antiproteasas and LDH as indicators of necrosis in human acute pancreatitis. Pancreas. 1991;6:253-9.
62. Viedma JA, Pérez-Mateo M, Agulló J, Domínguez JE, Carballo F. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut. 1994;35:822-7.
63. Demmy TL, Burch JM, Feliciano DV, Mattox KL, Jordan GL Jr. Comparison of multiple-parameter prognostic systems in acute pancreatitis. Am J Surg. 1988;156:492-6.
64. Pezzilli R, Billi P, Miniero R, Fiocchi M, Cappelleti O, Morselli-Labate AM, et al. Serum interleukin 6, interleukin 8 and a2 microglobulin in early assessment of severity of acute pancreatitis. Comparison with C reactive protein. Dig Dis Sci. 1995;40:2341-8.
65. Leser HG, Gross H, Scheibenbogen C, Heinisch A, Salm R, Lausen M, et al. Elevation of interleukin 6 concentration precedes acute phase response and reflect severity in acute pancrea-titis. Gastroenterology. 1991;101:782-5.
66. Heath DI, Cruikshand A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin 6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut. 1993;34:41-5.
67. De Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KHC. Serum concentration of inflammatory mediators related to organ failure with acute pancreatitis. Br J Surg. 1996;83:349-53.
68. Gross V, Schölmerich J, Leser HG, Salm R, Lausen M, Ruckauer K, et al. Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute phase protein C reactive protein, a1-antitrypsin and protease inhibitor a2-macroglobulin. Dig Dis Sci. 1990;35:97-105.
69. Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg. 1989;76:177-81.
70. Andren-Sandberg A, Borgström A. Early prediction of severity in acute pancreatitis. Is this possible? J Pancreas. 2003;3:116-25.
71. Chen CC, Wang SS, Lee FY, Chang FY, Lee SD. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol. 1999;94:213-8.
72. Armengol-Carrasco M, Oiler B, Escudero LE, Roca J, Gener J, Rodríguez N, et al. Specific prognostic factors for secondary pancreatic infection in severe acute pancreatitis. Dig Surg. 1999;16:125-9.
73. Rau B, Steinbach G, Gansauge F, Mayer JM, Grünert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut. 1997;41:832-40.
74. Müller CA, Uhl W, Printzen G, Gloor B, Bischofberger H, Tcholakov O, et al. Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis. Gut. 2000;46:233-8.
75. Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick MG, Slavin J, Beger HG, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet. 2000;355:1955-60.
76. Appelros S, Peterson U, Toh S, Johnson C, Borgström A. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br J Surg. 2001;88:216-21.
77. Windsor JA. Search for prognostic markers for acute pancreatitis. Lancet. 2000;355:1924-5.
78. Villalba Martín C, Rey Wonenburger M, Sáenz Bañuelos J. Diagnóstico y control evolutivo radiológico: ecografía, TAC morfológico y dinámico. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave, Manejo integral. Barcelona: Ed. SEMICYUC y EDIKA-med; 2003. p. 75-88.
79. Balthazar EJ, Ranson JHC, Naidich DP, Megibow AJ. Caccavale R, Cooper MM. Acute pancreatitis: prognostic value of CT. Radiology. 1985;156:767-72.
80. London NJM, Leese T, Lavelle JM, Miles K, West KP, Watkin DFL, et al. Rapid-bolus contrast-enhanced dynamic computed tomography in acute pancreatitis: a prospective study. Br J Surg. 1991;78:1452-6.
81. Balthazar EJ, Freeny PC, Van Sonnenberg E. Imaging and intervention in acute pancreatitis. Radiology. 1994;193:297-306.
82. Balthazar EJ. Contrast-enhanced Computed Tomography in Severe Acute Pancreatitis. En: Bradley EL, III, (editor) Acute pancreatitis: diagnosis and therapy. New York: Raven Press; 1994. p. 57-68.
83. Kemppainen E, Sainio V, Haapiainen R, Kivisaari L. Kivilaasko E, Puolakkainen P. Early localization of necrosis by contrast-enhanced computed tomography can predict outcome in severe acute pancreatitis. Br J Surg. 1996;83:924-9.
84. Balthazar EJ. Complications of acute pancreatitis. Clinical and CT evaluation. Radiol Clin North Am. 2002;40:1211-27.
85. Sánchez Morcillo S, Gener RJ, Casas D, Marcos NP. Rodríguez A, Fabrá RM. Valor pronostico de la TC inicial (primeras 48 horas) en los pacientes con Pancreatitis aguda. Med Intensiva. 2004;28(Supl 1);73 (P207).
86. Casas JD, Díaz R, Valderas G, Mariscal A, Cuadras P. Prognostic value of CT in the early assessment of patients with acute pancreatitis. Am J Roentgenelogy. 2004;182:569-74.
87. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JC. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990;174:331-6.
88. Balthazar EJ. Staging of acute pancreatitis. Radiol Clin North Am. 2002;40:1199-209.
89. Vesentini S, Bassi C, Talamini G, Cavalini G, Campedilli A, Pederzoli P. Prospective comparison of C-reactive protein level, Ranson score and contrast enhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg. 1993;80:755-7.
90. Moulton JS. The radiologic assessment of acute pancreatitis and its complications. Pancreas. 1991;6 Suppl 1:13-22.
91. Nuutinen P, Kivisaari L, Schroder T. Contrast enhanced computed tomography and microangiography of the pancreas in acute human hemorrhagic/necrotizing pancreatitis. Pancreas. 1988;3:53-60.
92. Bradley EL, Murphy F, Ferguson C. Prediction of pancreatic necrosis by dynamic pancreatography. Ann Surg. 1989;210:495-503.
93. Larvin M, Chalmers AG, McMahon MJ. Dynamic contrast enhanced CT: A precise technique for the identification of pancreatic necrosis. Br Med J. 1990;300:1425-8.
94. Pickford IR, Blackett RI, McMahon MJ. Early assessment of severity using peritoneal lavage. Br Med J. 1977;2:1377-9.
95. Balthazar E J, Freeny PC. Contrast enhanced computed tomography in acute pancreatitis: is it beneficial or harmful. Gastroenterology. 1994;106:259-62.
96. King NKK, Powell JJ, Redhead D, Siriwardena AK. A simple computed tomographic score for estimation of disease severity in acute pancreatitis. Pancreatology. 2003;3:223.
97. Lankisch P, Struckmann K, Lehnick D. Presence and extent of extrapancreatic fluid collections are indicators of severe acute pancreatitis. Int J Pancreatol. 1999;26:131-6.
98. Clasificación de las dosis efectivas características de la radiación ionizante procedente de las técnicas habituales de diagnóstico por la imagen. En: Comisión Europea. Guía de indicaciones para la correcta solicitud de pruebas de diagnóstico por imagen. Protección radiológica 118. Luxemburgo, Oficina de Publicaciones Oficiales de las Comunidades Europeas, 2001.
99. Robinson PJA, Sheridan MB. Pancreatitis: Computed tomography and magnetic resonance imaging. Eur Radiol. 2000;10:401-8.
100. Marion BM, van der Kolk, Ramsay G. Management of acute pancreatitis in the Intensive Care Unit. Curr Opin Crit Care. 2000;6:271-5.
101. Ramesh H, Prakash K, Lekna V, Jacob G, Venugopal A. Are some cases of Infected Necrosis Treatable without intervention? Dig Surg. 2003;20:296-300.
102. Lankisch PG, Blum T, Maisonneuve P, Lowenfels AB. Severe acute pancreatitis: when to be concerned? Pancreatology. 2003;3:102-10.
103. Gener Rexach J, Blanco Vicente A, Bolaños JA, Maraví-Poma E. Pancreatitis aguda grave en cuidados intensivos: aspectos epidemioló gicos, clínicos y complicaciones sistémicas. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave, Manejo integral. Barcelona: Ed. SEMICYUC y EDIKA-med; 2003. p. 41-52.
104. Tellería Martín A, Álvarez Lerma F, Bonet A. Tratamiento médico en UCI: prevención de las complicaciones y manejo conservador. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave, Manejo integral. Barcelona: Ed. SEMICYUC y EDIKA-med; 2003. p. 89-96.
105. Wilson C, Imrie CW, Carter DC. Fatal acute pancreatitis. Gut. 1988;29:782-8.
106. Mann DV, Hershman MJ, Hittinger R, Glazer G. Multicentre audit of death from acute pancreatitis. Br J Surg. 1994;81:890-3.
107. Bank S, Singh P, Pooran N, Stark B. Evaluation of factors that have reduced mortality from acute pancreatitis over the past 20 years. J Clin Gastroenterol. 2002;35:50-60.
108. Radnay PA, Brodman E, Mankikar D, Duncalf D. The effect of equianalgesic doses of fentanyl, morphine, meperidine and pentazocine on common bile duct pressure. Anaesthesist. 1980;29:26-9.
109. Staritz M, Poralla T, Manns M, Meyer Zum Buschenfelde KH. Effect of modern analgesic drugs (tramadol, pentazocine, and buprenorphine) on the bile duct sphincter in man. Gut. 1986;27:567-9.
110. Thune A, Baker RA, Saccone GT, Owen H, Toouli J. Differing effects of pethidine and morphine on human sphinter of Oddi motility. Br J Surg. 1990;77:992-5.
111. Isenhower HL, Mueller BA. Selection of narcotic analgesics for pain associated with pancreatitis. Am J Health Syst Pharm. 1998;55:480-6.
112. Gil Cebrián J, Bello Cámara MP, Rodríguez Yáñez JC, Fernández Ruiz A. Analgesia y sedación en la pancreatitis aguda. Med Intensiva. 2003;27:118-30.
113. Lévy P, Hastier P, Arotçarena R, Bartolie E, Bougeard-Julien M, Blumberg J, et al. Efficacy of Lanreotide 30 mg on prevention of pain relapse alter oral refeeding in patients with Necrotizing Acute Pancreatitis. A Phase II prospective multicentre study. Pancreatology. 2004;4:229-32.
114. Levy P, Heresbach D, Pariente EA, Boruchowicz A, Delcenserie R, Millat B, et al. Frequency and risk factors or recurrent pain during refeeding in patients with acute pancreatitis. A multivariate multicentre prospective study of 116 patients. Gut. 1997;40:262-6.
115. Klar E. Isovolemic hemodilution with dextran 60 as treatment of pancreatic ischemia in acute pancreatitis. Ann Surg. 1993;217:369-74.
116. Brown A, Baillargeon J-D, Hughes MD, Banks PA. Can fluid resuscitation prevent pancreatic necrosis in severe acute pancreatitis? Pancreatology. 2002;2:104-7.
117. Marshall JB. Acute pancreatitis. Review with an emphasis on new developments. Arch Intern Med. 1993;153:1185-98.
118. Pupelis G, Austrums E, Snippe K, Berzins M. Clinical significance of increased intraabdominal pressure in severe acute pancreatitis. Acta Chir Belg. 2002;102:71-4.
119. Pupelis G, Austrums E, Snippe K, Melbarde-Gorkusa I. Increased intra-abdominal pressure an important risk factor of early organ dysfunction in severe acute pancreatitis. Zentralbl Chir. 2002;127:982-6.
120. Malbrain ML. Different techniques to measure intra-abdominal pressure (IAP): time for a critical reappraisal. Intensive Care Med. 2004;30:357-71.
121. Gecelter G, Fahoun B, Gardezi S, Schein M. Abdominal compartment syndrome in severe acute pancreatitis. An indication for a decompressing laparotomy? Dig Surg. 2002;19:402-4
122. Maraví-Poma E, Jiménez I, Martínez J M, Escuchuri J, Izura J. Abdominal Compartmental Syndrome, Severe Acute Pancreatitis and Percutaneos Decompressive Peritoneal. Intensive Care Med. 2003;29:S185.
123. Echenique Martínez S, Acosta A, Zevallos J, Valverde J. La pancreatitis aguda grave en América Latina. Manejo en Intensivos y soporte nutricional. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave: Manejo Integral. Barcelona: Ed. SEMICYUC y EDIKA-Med; 2003. p. 119-30.
124. Ortiz Leyba C. Nutrición artificial en las pancreatitis agudas graves. Med Intensiva. 2003;27:131-6.
125. Sax HC, Warner BW, Talamini MA. Early total parenteral nutrition in acute pancreatitis: lack of beneficial effects. Am J Surg. 1987;153:117-24.
126. ESPEN guidelines on nutrition in acute pancreatitis. Clin Nutr. 2002;21:173-83.
127. Schneider H, Boyle N, McCluckie A, Beal R, Atkinson S. Acute severe pancreatitis and multiple organ failure: total parenteral nutrition is still required in a proportion of patients. Br J Surg. 2000;87:362-73.
128. Van Gossum A, Lemoyne M, Greig PD, Jeejeebhoy KN. Lipid-associated total parenteral nutrition in patients with severe acute pancreatitis. J Parent Enteral Nutr. 1988;12:250-5.
129. Robin AP, Campbell R, Palani K, Liu K, Donahue PE, Nyhus LM. Total parenteral nutrition in severe acute pancreatitis: clinical experience with 156 patients. World J Surg. 1990;14:572-9.
130. Kalfarentzos FE, Karavias DD, Karatzas TM, Alevizatos BA, Androulakis JA. Total parenteral nutrition in severe acute pancreatitis. J Am Coll Nutr. 1991;10:156-62.
131. Kalfarentzos FE, Kehagias J, Mead N, Kokkinis K, Gogos CA. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg. 1997;84:1665-9.
132. Al-Omran M, Groof A, Wilke D. Nutrición enteral versus parenteral para la pancreatitis aguda. En: Cochrane Library plus en espanol. Oxford: Update Software 2002
133. (De: Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev. 2001;(2):CD002837. Update Software 2003).
134. Woodcock CJ, MacFie J. Enteral versus parenteral nutrition: a pragmatic study. Nutrition. 2001;17:1-12.
135. Marulendra S, Kirby DF. Nutrition support in Pancreatitis. Nutr Clin Pract. 1995;10:45-53.
136. Scolapio JS, Malhi-Chowla N, Ukleja A. Nutrition supplementation in patients with acute and chronic pancreatitis. Gastroenterol Clin North Am 1999;28:695-707.
137. Jiménez Urra I, Lander Azcona A, Gutiérrez Oliver, Martínez Segura J. Soporte nutricional en la pancreatitis aguda grave en UCI: Nutrición parenteral total frente a nutrición enteral. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave: Manejo Integral. Barcelona: Ed. SEMICYUC y EDIKA-Med; 2003. p. 131-6.
138. Tesinsky P. Nutritional care of pancreatitis and its complications. Curr Opin Clin Nutr Metab Care. 1999;2:395-8.
139. de Beaux AC, O'Riordain MG, Ross JA, Jodozi L, Carter DC, Fearon KC. Glutamine-supplemented total parenteral nutrition reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis. Nutrition. 1998;14:261-5.
140. Ockenga J, Borchert K, Rifai K, Manns MP, Bischoff SC. Effect of glutamine-enriched total parenteral nutrition in patients with acute pancreatitis. Clin Nutr. 2002;21:409-16.
141. Neoptolemos JP, Carr-Locke DL, London NJ, Bailey IA, James D, Fossard DP. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet. 1988;2:979-83.
142. Fan ST, Lai EC, Mok FP, Lo CM, Zheng SS, Wong J. Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med. 1993;328:228-32.
143. Folsch UR, Nitsche R, Ludtke R, Hilgers RA, Creutzfeldt W. Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis. N Engl J Med. 1997;336:237-42.
144. Jover R, Llach J, Bordas JM, Mas A, Salmeron JM, Navarro S, Terés J. Utilidad de la precocidad de la esfinterotomía endoscópica en la pancreatitis aguda grave de origen biliar. Gastroenterol Hepatol. 1997;20:344-6.
145. Kraft M, Lerch MM. Gallstone pancreatitis: when is endoscopic retrograde cholangiopancreatography truly necessary? Curr Gastroenterol Rep. 2003;5:125-32.
146. Eguaras J, Jiménez López C, Susperregui Insausti I, Vila Costas JJ, Martínez Segura JM. Primera Parte: Pancreatitis Aguda y Colangio Pancreatografía Retrograda Endoscópica (CPRE). Segunda Parte: Secuelas a Largo Plazo de las Pancreatitis Agudas Graves (PAG) Post-UCI. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave: Manejo Integral. Barcelona: Ed. SEMICYUC y EDIKA-Med; 2003. p. 137-46.
147. Pederzoli P, Bassi C, Vesentini S, Campedelli A. A randomized, multicenter, clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with Imipenem. Surg Gynecol Obstet. 1993;176:480-3.
148. Sainio V, Kemppainen E, Puolakkainen P, Taavitsainen M, Kivisaari L, Valtonen V, et al. Early antibiotic treatment in acute necrotizing pancreatitis. Lancet. 1995;346:663-7.
149. Ho HS, Frey CF. The role of antibiotic prophylaxis in severe acute pancreatitis. Arch Surg. 1997;132:487-92.
150. Pearce NW, Johnson CD. Antibiotic use during the study of Lexipafant in Severe Acute Pancreatitis. Int J Pancreatol. 1999;25:234.
151. Smietanski M, Lukianski M, Pirski MI, Sledzinski Z. Tazocin (piperaciyllin plus tazobactam sodium) in treatment of severe acute pancreatitis -First or second- choice medication? Infect Control Hosp Epidemiol. 2000;21:423.
152. Manes G, Rabitti PG, Menchise A, Riccio E, Balzano A, Uomo G. Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem. Pancreas. 2003;27:79-83.
153. Delcenserie R, Yzet T, Ducroix JP. Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas. 1996;13:198-201.
154. Schwarz M, Isenmann R, Meyer H, Beger HG. Antibiotika bei nekrotisierender Pankreatitis. Ergebnisse einer kontrollierten Studie. Dtsch Med Wochenschr. 1997;122:356-61.
155. Gloor B, Müller CA, Worni M, Stahel PF, Redaelli C, Uhl W, et al. Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch Surg. 2001;136:592-6.
156. De Waele JJ, Vogelaers D, Blot S, Colardyn F. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis. 2003;37:208-13.
157. Maraví-Poma E, Martínez Segura JM, Lander Azcona A. Pancreatitis Aguda desde la Perspectiva de la Medicina Intensiva y Crítica. Antibioterapia Profiláctica: Argumentos a favor. Med Intensiva. 2003;27:101-9.
158. Sierra Camerino R. ¿Antibioterapia profiláctica en la pancreatitis aguda grave? Med Intensiva. 2003;27:110-7.
159. A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects with Severe Acute Necrotizing Pancreatitis. Study Code: 3591IL/0089.
160. Bassi C, Falconi M, Talamini G, Uomo G, Papaccio G, Dervenis C, et al. Controlled clinical trial of Pefloxacin versus Imipenem in Severe Acute Pancreatitis. Gastroenterology. 1998; 115:1513-7.
161. Maraví-Poma E, Martínez Segura JM, Martínez García A, López Camps V. Antibióticos en la sepsis pancreática. Prevención de la infección pancreática secundaria. Estado actual. Primera parte: Antibióticos en la PAG con necrosis pancreática. Sistémicos. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave: Manejo Integral. Barcelona: Ed. SEMICYUC y EDIKA-Med; 2003. p. 97-112.
162. McClelland P, Murray A, Yaqoob M, Van Saene HK, Bone JM, Mostaza SM. Prevention of bacterial infection and sepsis in acute severe pancreatitis. Ann R Coll Surg Engl. 1992;74:329-34.
163. Luiten EJT, Hop WC, Lanje JF, Bruining HA. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg. 1995;222:57-65.
164. Sánchez M, Trascasa M, Álvarez M, Nevado E, DePablo R, Cambronero JA. Selective decontamination for prevention of infection in Severe Pancreatitis. A randomized-Control trial. Intensive Care Med. 2000;26:S334.
165. Luiten EJT, Hop WCJ, Lange JF, Bruining HA. Differential prognosis of Gram negative versus Gram positive infected and sterile pancreatic necrosis: results of a randomized trial in patients with severe acute pancreatitis treated with adjuvant selective decontamination. Clin Infect Dis. 1987;25:811-6.
166. Krueger WA, Heiningen A, Unertl KE. Selective digestive tract decontamination in intensive care medicine. Fundamental and current evaluation. Anaesthesist. 2003;52:142-52.
167. Sánchez García M, Trascasa M. Antibióticos en la sepsis pancreática. Prevención de la infección pancreática secundaria. Estado actual. Segunda parte: Alternativas a los antibióticos intravenosos. Resucitación de volumen, alimentación enteral y descontaminación digestiva selectiva. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave: Manejo Integral. Barcelona: Ed. SEMICYUC y EDIKA-Med; 2003. p. 113-8.
168. Herrera Gutiérrez ME, Seller Pérez G, de la Rubia de Gracia C, Chaparro Sánchez MJ, Nacle López B. Características y valor pronóstico del fracaso renal agudo en la pancreatitis aguda grave. Med Clin. 2000;115:721-5.
169. Mao E, Tang Y, Zhang S. Effects of time interval for hemofiltration on the prognosis of severe acute pancreatitis. World J Gastroenterol. 2003;9:373-6.
170. Wang H, Li W, Zhou W, Li N, Li J. Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol. 2003;9:2096-9.
171. Pupelis G, Austrums E, Snippe K. Blood purifications methods for treatment of organ failure in patients with severe pancreatitis. Zentralbl Chir. 2001;126:780-4.
172. Yekebas EF, Treede H, Knoefel WT, Bloechle C, Fink E, Izbicki JR. Influenze of Zero-Balanced Hemofiltration on the course of severe experimental Pancreatitis in pigs. Ann Surg. 1999;229:514-22.
173. Yekebas EF, Eisenberger C, Ohnesorge H, Saalmuller A, Elsner H, Engelhart M, et al. Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 2001;29:1423-30
174. Yekebas EF, Strate T, Zolmajd S, Eisenberger C, Ersbersdoblers A, Saalmuller A, et al. Impact of different modalities of continuous hemofiltration on sepsis-induced alterations in experimental pancreatitis. Kidney Int. 2002;62:1806-18.
175. Wilson PG, Manji M, Neoptolemos JP. Acute pancreatitis as a model of sepsis. J Antimicrob Chemother. 1998;41(Suppl A):51-63.
176. Ogawa M. Acute pancreatitis and cytokines: "second attack" by septic complication leads to organ failure. Pancreas. 1998;16:312-5.
177. Mayer AD, McMahon MJ, Corfield AP, Cooper MJ, Willianson RCN, Chir M, et al. Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. New Eng J Med. 1985;312:399-404.
178. Ranson JC, Berman RS. Long peritoneal lavage decreases pancreatitis sepsis in acute pancreatitis. Ann Surg. 1990;211:708-18.
179. Kellum A, Angus D, Johnson J, Leblanc M, Griffin M, Ramakrishnan N, et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med. 2002;28:29-37.
180. Díaz-Regañón G, Fernández R, Martínez C, Ortiz M, García L, González S. La hemofiltración arteriovenosa continua en el tratamiento del síndrome de distrés respiratorio del adulto y del síndrome de disfunción multiorgánica. Med Intensiva. 1995;19:449-53.
181. Takeda K, Sunamura M, Dhibuya K, Kobari M, Matsuno S. Role of early continuous arterial infusion of protease inhibitor and antibiotic in nonsurgical treatment of acute necrotizing pancreatitis. Digestion. 1999;60:9-13.
182. McKay C, Baxter J, Imrie C. A randomized, controlled trial of octreotide in the management of patients with acute pancreatitis. Int J Pancreatol. 1997;21:13-9.
183. Planas M, Perez A, Iglesia R, Porta I, Masclans JR, Bermejo B. Severe acute pancreatitis: treatment with somatostatin. Intensive Care Med. 1998;24:37-9.
184. Uhl W, Büchler MW, Malfertheiner P, Beger HG, Adler G, Gaus W. A randomized, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut. 1999;45:97-104.
185. Büchler M, Malfertheiner P, Uhl W, Scholmerich J, Stockmann F, Adler G, et al. Gabexate mesilate in human acute pancreatitis. Gastroenterology. 1993;104:1165-70.
186. Chen HM, Chen JC, Hwang TL, Jan YY, Chen MF. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Hepatogastroenterol. 2000;47:1147-50.
187. Bhatia M. Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr Drug Targets Inflamm Allerg. 2002;1:343-51.
188. Bernard GR, Vincent JL, Laterre PF, La Rosa SP, Dhainaut JF, López-Rodríguez A. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
189. Maraví-Poma E, Lander Azcona A, Martínez Segura JM, Olaechea Astigarraga P. Sepsis Pancreática en Intensivos e Infecciones Nosocomiales Extrapancreáticas: Infección de la necrosis y Absceso pancreático. Patogenia. Identificación de la infección pancreática: El papel de la aspiración con punción percutánea radio dirigida y bacteriología. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave, Manejo integral. Barcelona: Ed. SEMICYUC y EDIKA-med; 2003. p. 53-62.
190. Maraví-Poma E, Jiménez Urra I. Pancreatitis Aguda Grave y Sepsis Pancreática. En: Álvarez B coordinador. Medicina Crítica Práctica. Sepsis Grave de Origen Abdominal. Barcelona. Ed. EdikaMED y SEMICYUC; 2004. p. 71-88.
191. Uomo G, Visconti M, Manes G, Cause F, Laccetti M, Rabitti PG. Nonsurgical treatment of acute necrotizing pancreati-tis Pancreas. 1996;12:142-8.
192. Paye F, Rotman N, Radier C, Nouira R, Fagniez PL. Percutaneous aspiration for bacteriological studies in patients with necrotizing pancreatitis. Br J Surg. 1998;85:755-9.
193. Hiatt JR, Fink AS, King W III, Pitt HA. Percutaneous aspiration of peripancreatic fluid collections: a safe method to detect infection. Surgery. 1987;101:523-30.
194. Gerzof SG, Banks PA, Robbins AH, Johnson WC, Spechler SJ, Wetzner SM, et al. Early diagnosis of pancreatic infection by computed tomography-guided aspiration. Gastroenterology. 1987;93:1315-20.
195. Stiles GM, Berne TV, Tomen VD, Molgaard CP, Boswell WD. Fine needle aspiration of pancreatic fluid collections. Am Surg. 1990;56:764-8.
196. Banks PA, Gerzof SG, Langevin RE, Silverman SG, Sica GT, Hughes MD. CT-guided aspiration of suspected pancreatic infection: bacteriology and clinical outcome. Int J Pancreatol. 1995;18:165-70.
197. Rau B, Pralle U, Mayer JM Beger HG. Role of ultrasonographically guided fine-needle aspiration cytology in the diagnosis of infected pancreatic necrosis. Br J Surg. 1998;85:179-84.
198. Bradley EL. Surgical desbridement is rarely necessary in sterile pancreatic necrosis. Pancreas. 1996;13:220-2.
199. Bradley EL. Operative vs. nonoperative therapy in necrotizing pancreatitis. Digestion. 1999;60(Suppl 1):19-21.
200. Rau B, Uhl W, Büchler MW, Beger HG. Surgical treatment of infected necrosis. World J Surg. 1997;21:155-61
201. Carter CR, McKay CJ, Imrie CW. Percutaneous necrosectomy and sinus tract endoscopy in the management of infected pancreatic necrosis: initial experience. Ann Surg. 2000;232:175-80.
202. Freeny PC, Hauptmann E, Althaus SJ, Traversa LW, Sinanan M. Percutaneous CT-guided catheter drainage of infected acute necrotizing pancreatitis: techniques and results. Am J Roentgenol. 1998;170:969-75.
203. Echenique AM, Sleeman D, Yrizarry J, Scagnelli T, Guerra JJ Jr, Casillas VJ, et al. Percutaneous catheter-directed desbridement of infected pancreatic necrosis: results in 20 patients. J Vasc Interv Radial. 1998;9:565-71.
204. Warshaw AL, Jin GL. Improved survival in 45 patients with pancreatic abscess. Ann Surg. 1985;202:408-17.
205. Pemberton JH, Becker JM, Dozois RR, Nagorney DM, Ilstrup D, Remine WH. Controlled open lesser sac drainage for pancreatic abscess. Ann Surg. 1986;203:600-13.
206. Beger H, Bittner R, Block S, Büchler M. Bacterial contamination of pancreatic necrosis: a prospective clinical study. Gastroenterology. 1986;91:433-8.
207. McClave SA, McAllister EW, Karl RC, Nord HJ. Pancreatic abscess: 10-year experience at the University of South Florida. Am J Gastroenterol. 1986;81:80-4.
208. Stanten R, Frey CF. Comprehensive management of acute necrotizing pancreatitis and pancreatic abscess. Arch Surg. 1990;125:269-75.
209. Rotman N, Mathieu D, Anglade MC, Fagniez PL. Failure of percutaneous drainage of pancreatic abscesses complicating severe acute pancreatitis. Surg Gynecol Obstet. 1992;174:141-4.
210. Lang EK, Paolini RM, Pottméyer A. The efficacy of palliative and definitive percutaneous versus surgical drainage of pancreatic abscesses and pseudocysts: a prospective study of 85 patients. South Med J. 1991;84:55-64.
211. Mithöfer K, Mueller PR, Warshaw AL. Interventional and surgical treatment of pancreatic abscess. World J Surg. 1997;21:162-8.
212. Adams D, Harvey T, Anderson M. Percutaneous catheter drainage of infected pancreatic and peripancreática fluid collections. Arch Surg. 1990;125:1554-7.
213. VanSonnenberg E, Wittich GR, Casola G, Brannigan TC, Kernel F, Stabile BE, et al. Percutaneous drainage of infected and noninfected pancreatic pseudocysts: experience in 101 cases. Radiology. 1989;170:757-61.
214. vanSonnenberg E, Wittich GR, Chon KS, D'Agostino HB, Casola G, Easter D, et al. Percutaneous radiologic drainage of pancreatic abscesses. Am J Roentgenol. 1997;168:979-84.
215. Yeo CJ, Bastidas JA, Lynch-Nyhan A, Fishman EK, Zinder MJ, Cameron JL. The natural history of pancreatic pseudocysts documented by computed tomography. Surg Gynecol Obstet. 1990;170:411-7.
216. Vitas GJ, Sarr MG. Selected management of pancreatic pseudocysts: operative versus expectant management. Surgery. 1992;111:123-30.
217. Adams D, Harvey T, Anderson M. Percutaneous catheter drainage of pancreatic pseudocysts. Am Surg. 1991;57:29-33.
218. D'Egidio A, Schein M. Percutaneous drainage of pancreatic pseudocysts: a prospective study. World J Surg. 1991;16:141-6.
219. Andersson R, Janzon M, Sundberg I, Bengmark S. Management of pancreatic pseudocysts. Br J Surg. 1989;76:550-2.
220. Grosso M, Gandini G, Cassinis MC, Regge D, Righi D, Rossi P. Percutaneous treatment (including pseudocystograstrostomy) of 74 pancreatic pseudocysts. Radiology. 1989;173:493-7.
221. Martínez I, Navarro S, Fernández-Cruz L, Díaz de Liaño Argüelles A. El papel de la cirugía en la pancreatitis aguda grave: perspectiva histórica; estado actual. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave: Manejo Integral. Barcelona: Ed. SEMICYUC y EDIKA-Med; 2003. p. 147-54.
222. Barreda Cevasco LA, Targarona Modena J, Carbajal Nicho R. La pancreatitis aguda grave en América Latina. Manejo quirúrgico. En: Medicina Crítica Práctica. Pancreatitis Aguda Grave: Manejo Integral. Barcelona: Ed. SEMICYUC y EDIKA-Med; 2003. p. 155-64.
223. Beger HG, Rau B, Mayer J, Pralle U. Natural course of acute pancreatitis. World J. Surg. 1997;21:130-5.
224. Yousaf M, McCallion K, Diamond T. Management of severe acute pancreatitis. Br J Surg. 2003;90:407-20.
225. Büchler M, Uhl W, Beger HG. Acute pancreatitis: when and how to operate. Dig Dis. 1992;10:354-62.
226. Beger HG. Surgery in acute pancreatitis. Acta Hepatogastroenterol. 1991;38:92-6.
227. Ihse I, Andersson R, Andren-Sandberg A, Axelson J, Kobari M. Conservative treatment in acute pancreatitis. Ann Ital Chir. 1995;66:181-5.
228. Rau B, Pralle U, Uhl W, Schoenberg MH, Beger HG. Management of sterile necrosis in instances of severe acute pancreatitis. J Am Coll Surg. 1995;181:279-88.
229. Gotzinger P, Wamser P, Exner R, Schwanzer E, Jakesz R, Fugger R, et al. Surgical treatment of severe acute pancreatitis: timing of operation is crucial for survival. Surg Infect (Larchmt.). 2003;4:205-11.
230. Hartwig W, Maksan SM, Foitzik T, Schmidt J, Herfarth C, Klar E. Reduction in mortality with delayed surgical therapy of severe pancreatitis. J Gastrointest Surg. 2002;6:481-7.
231. Mier J, Leon EL, Castillo A, Robledo F, Blanco R. Early versus late necrosectomy in severe necrotizing pancreatitis. Am J Surg. 1997;173:71-5.
232. Gloor B, Uhl W, Büchler MW. Changing concepts in the surgical management of acute pancreatitis. Baillieres Best Pract Res Clin Gastroenterol. 1999;13:303-15.
233. Uhl W, Warshaw A, Imrie C, Bassi C, McKay CJ, Lankisch PG, et al. IAP Guidelines for the Surgical Management of Acute Pancreatitis. Pancreatology. 2002;2:565-73.
234. Schoenberg MH, Rau B, Beger HG. New approaches in surgical management of severe acute pancreatitis. Digestion. 1999;60 Suppl 1:22-6.
235. Le Mee J, Paye F, Sauvanet A, O'Toole D, Hammel P, Marty J, et al. Incidence and reversibility of organ failure in the course of sterile or infected necrotizing pancreatitis. Arch Surg. 2001;136:1386-90.
236. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. NIH Consens State Sci Statements. 2002;19:1-26.
237. Mitchell RM, Byrne MF. Biliary emergencies: pancreatitis, cholangitis, and more. Semin Gastrointest Dis. 2003;14:77-86.
238. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol. 1999;25:195-210.
239. Farkas G, Marton J, Mandi Y, Szederkenyi E. Surgical strategy and management of infected pancreatic necrosis. Br J Surg. 1996;83:930-3.
240. Hartwig W, Werner J, Uhl W, Büchler MW. Management of infection in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2002;9:423-8.
241. Wyncoll DL. The management of severe acute necrotising pancreatitis: an evidence-based review of the literature. Intensive Care Med. 1999;25:146-56.
242. Isenmann R, Beger HG. Natural history of acute pancreatitis and the role of infection. Baillieres Best Pract Res Clin Gastroenterol. 1999;13:291-301.
243. Beger HG, Isenmann R. Surgical management of necrotizing pancreatitis. Surg Clin North Am. 1999;79:783-800.
244. Hartwig W, Werner J, Müller CA, Uhl W, Büchler MW. Surgical management of severe pancreatitis including sterile necrosis. J Hepatobiliary Pancreat Surg. 2002;9:429-35.
245. Isenmann R, Rau B, Beger HG. Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas. 2001;22:274-8.
246. Isenmann R, Rau B, Zoellner U, Beger HG. Management of patients with extended pancreatic necrosis. Pancreatology. 2001;1:63-8.
247. Fernández-del Castillo C, Rattner DW, Makary MA, Mostafavi A, McGrath D, Warshaw AL. Debridement and closed packing for the treatment of necrotizing pancreatitis. Ann Surg. 1998;228:676-84.
248. Adler DG, Chari ST, Dahl TJ, Farnell MB, Pearson RK. Conservative management of infected necrosis complicating severe acute pancreatitis. Am J Gastroenterol. 2003;98:98-103.
249. United Kingdom guidelines for the management of acute pancreatitis. British Society of Gastroenterology. Gut. 1998;42:S1-13.
250. Nordback IH, Auvinen OA. Long-term results after pancreas resection for acute necrotizing pancreatitis. Br J Surg. 1985; 72:687-9.
251. Wilson C, McArdle CS, Carter DC, Imrie CW. Surgical treatment of acute necrotizing pancreatitis. Br J Surg. 1988;75:1119-23.
252. Beger HG, Rau B. Necrosectomy and postoperative local lavage in necrotizing pancreatitis. Ann Ital Chir. 1995;66:209-15.
253. Bradley EL, III. A fifteen-year experience with open drainage for infected pancreatic necrosis. Surg Gynecol Obstet. 1993;177:215-22.
254. Sarr MG, Nagorney DM, Mucha P, Jr, Farnell MB. Johnson CD. Acute necrotizing pancreatitis: management by planned, staged pancreatic necrosectomy/desbridement and delayed primary wound closure over drains. Br J Surg. 1991;78:576-81.
255. Hedderich GS, Wexler MJ, McLean AP, Meakins JL. The septic abdomen: open management with Marlex mesh with a zipper. Surgery. 1986;99:399-408.